0001209191-21-071507.txt : 20211229
0001209191-21-071507.hdr.sgml : 20211229
20211229173138
ACCESSION NUMBER: 0001209191-21-071507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211227
FILED AS OF DATE: 20211229
DATE AS OF CHANGE: 20211229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEDEL ROGER MD
CENTRAL INDEX KEY: 0001093125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12111
FILM NUMBER: 211529886
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDNAX, INC.
CENTRAL INDEX KEY: 0000893949
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 263667538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
BUSINESS PHONE: 9543840175
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
FORMER COMPANY:
FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC
DATE OF NAME CHANGE: 19950801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-27
0
0000893949
MEDNAX, INC.
MD
0001093125
MEDEL ROGER MD
1301 CONCORD TERRACE
SUNRISE
FL
33323
1
0
0
0
Common Stock
2021-12-27
4
S
0
66868
27.17
D
1060925
D
Common Stock
2021-12-28
4
S
0
44514
27.28
D
1016411
D
Common Stock
2021-12-29
4
S
0
25000
27.28
D
991411
D
Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.84 to $27.48 for a weighted average sales price of $27.17. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from
$27.15 to $27.71 for a weighted average sales price of $27.28. The reporting person undertakes to provide the issuer, any security holder of the
issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each
separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.98 to $27.43 for a weighted average sales price of $27.28. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Dominic J. Andreano, Attorney-in-Fact
2021-12-29